Abstract. 12(S)-HETE, a lipoxygenase metabolite of arachidonic acid induced a nondestructive and reversible endothelial cell (EC) retraction. 12(S)-HETE induced EC retraction was inhibited by protein kinase C inhibitors calphostin C and staurosporine but not by the protein kinase A inhibitor HS. The role of EC integrins otv/33 and ot5/31 in 12(S)-HETE induced EC retraction was investigated. In confluent EC cultures, ctv~/3 is localized to focal adhesions at both the cell body and cell-cell borders and is colocalized with vinculin-containing focal adhesions. In contrast, c~5/31 is primarily enriched at the cell-cell borders, demonstrating codistribution with cell cortical microfilaments and extraceUular fibronectin. Both receptors were functional in mediating cell-cell or cell-matrix interactions based on the observations that specific antibodies inhibited EC adhesion to intact subendothelial matrix and disrupted the monolayer integrity. 12(S)-HETE induced a multistep, temporally defined redistribution of the o~v/33-containing focal adhesions, leading to an eventual decrease in otv/33 plaques in the retracted ECs. This effect of 12(S)-HETE was inhibited by calphostin C but not by H8. The alterations of o~v~3-containing focal adhesions preceded the development of EC retraction. 12(S)-HETE also enhanced EC otv/33 surface expression as revealed by immunofluorescence, flow cytometry, and digitized image analysis. 12(S)-HETE-induced o~v/33 rearrangement (i.e., decreased focal adhesion localization and enhanced surface expression) did not result from altered mRNA transcription (as revealed by semi-quantitative RT-PCR analysis) or protein translation (as revealed by Western blotting). In contrast to its effect on c~v/33, 12(S)-HETE did not demonstrate a temporally related, well-defined effect on the distribution pattern and the surface expression of ot5/31, although the cell-cell border staining pattern of ot5/~l was disrupted due to EC retraction. It is concluded that 12(S)-HETE-induced decrease of c~v/33 localization to focal adhesions may contribute to the development of EC retraction and that 12(S)-HETE induced increase in ~v~3 surface expression may promote adhesion of inflammatory leukocytes as well as tumor cells to endothelium.
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NDOTHELIAL cells (ECs) ~ express diverse cell surface receptors which mediate cell-cell and cell-matrix interactions. Among these receptors are Ca 2+-dependent and -independent adhesion molecules involved in intercellular adhesion (Bavisotto et al., 1990; Albelda et al., 1990) and integrins mediating both cell-cell and cell-matrix interactions (Ruoslahti, 1991) . All integrins are transmembrahe heterodimers composed of c~ and/~ subunits and are connected, via the carboxyl-terminal end of either the o~ chain or the/~ chain (or both), to the eytoskeleton (primarily microfilament), thus possibly establishing an inductive communication across the membrane. Originally, these glycoprotein complexes were classified into three major subfamilies (El, /~2, and/~3) based on a common/3 subunit in association with different o~ subunits (Hynes, 1987) . However, other ~/subunits expressed on epithelial cells, fibroblasts, or some carcinoma cells have been described. To date, at least 20 integrins formed from various combinations of 12 ot subunits and 9 subunits have been reported (Ruoslahti, 1991; Hynes and Lander, 1992; Honn and Tang, 1992) .
Knowledge of EC integrins stemmed from the observation that vascular ECs synthesize a membrane protein that is immunologically and biochemically related to the platelet glycoprotein otllb//33 complex (Fitzgerald et al., 1985) . EC otlIb//33-1ike receptors were later identified to be the vitronectin receptor (otv#3), which shares the/33 subunit with otlIb//~3 and mediates EC adhesion to fibrinogen, vitronectin, von Willebrand factor (Cheresh, 1987; Dejana et al., 1990; Albelda et al., 1989) , thrombospondin (Lawler et al., 1988) , laminin (Kramer et al., 1990) , fibronectin (Cheng et al., 1991; Charo et al., 1990) , and possibly collagen (Agrez et al., 1991) . The reason why ctv/~3 is such a promiscuous and versatile integrin receptor for so many different ligands (in contrast to o~5/31, which specifically mediates cell adhesion to fibronectin) may be explained by the fact that the ore subunit, in addition to E3, is able to associate with several other E subunits, such as El, E5, E6,/~8, and a Es subunit in an osteosarcoma cell line (for review see Honn and Tang 
Materials and Methods

Cell Culture
Microoascular ECs (CD3) were isolated from mouse pulmonary microvessels, cloned and characterized as described previously (Chopra et al., 1990) . Large vessel ECs (rat aortic EC or RAEC) were isolated from Sprague-Dawley rat aortic rings as described p~viously (Diglio et ai., 1982) . These ECs were routinely maintained in DME supplemented with 10% FCS (GIBCO BRL, Gaithersburg, MD). Cells were cultured in a humidified atmosphere with 5% CO2, and the culture medium was changed every 48 h.
Chemicals and Antibodies
12(S)-HETE was purchased from Cayman Chemical (Ann Arbor, MI). Type IV collagen and laminin were isolated from Englebreath-Holm-Swarm murine sarcomas (Chemicon, Segundo, CA). Fibronectin was isolated from human plasma by affinity chromatography (GIBCO BRL). Vitronectin was affinity purified from bovine serum using monospecific antibodies (GIBCO BRL). The protein kinase inhibitor, staurosporine (the ICso values for PKC = 0.0027 #M, for PKA = 0.0082 t~M, for cGMP-dependent protein kinase --0.031 #M, and for myosin light chain kinase = 0.0019 #M), was obtained from BIOMOL Res. Labs. Inc., (Plymouth Meeting, PA). PKC inhibitor, caiphostin C (the ICso values for PKC = 0.05 #M, for PKA > 50 #M, for cGMP-dependent protein kinase >25 ~tM, and for myosin light chain kinase >5 #M), was isolated from Cladosporium cladosporioides (Kamiya Biochem Co., Thousand Oaks, CA). The protein kinase A (FKA) inhibitor, H8 (the ICso values for PKC = 15 #M, for PKA --1.2 #M, for cGMP-dependent protein kinase = 0.48 #M, and for myosin light chain kinase = 68 #M), was purchased from Seikngaku America, Inc. (St. Petersburg, FL). Rhodamine-conjngated pballoidin was purchased from Molecular Probes Inc. (Eugene, OR). Fhorescein (FITC)-or Rhodamine-labeled goat anti-mouse, rabbit anti-goat and goat anti-rabbit IgG were obtained from ICN (Lisle, IL). Monoclonai anti-vinculin antibody was purchased from the Boeringer Mannheim Corp. (Indianapolis, IN) . A mAb against human platelet glycoprotein ~IIb//33 (7E3) which cross reacts with the EC c~v~3 but not a5~l (Fitzgerald and Phillips, 1989; Cbaro et al., 1987) , was kindly provided by Dr. B. S. Coller (Stony Brook, NY). A mAb (OPG-2) recognizing the/33 subunit was kindly provided by Dr. T. J. Kunicki (The Blood Center, WI). Polyclonal anti-otv/~3 and anti-~5/~l were raised in rabbit (Chemicon International, Temecnia, CA). Goat antibody to 0~5/31 and monoclonal anti-human o~v (clone VNR 147) were obtained from Telios Pharmaceuticals Inc. (San Diego, CA). The specificity of these antibodies was characterized by immunoblotting and immunoprecipitation. Two polyclonal antibodies to ~5/~1 stained identical bands on Western blots, i.e., a ll0-kD band under nonreducing conditions and a 130-kD band under reducing conditions (data not shown), which represents the/~1 subunit of the c~5~31 receptor. Rabbit anti-otv~3 immunoprecipitated a 110-and a 130-kD band under reducing conditions and a 90-and a 150-kD band under nomeducing conditions (data not shown), which corresponded to the 83 and ~v subunits, respectively. Rabbit anti-c~5/~l, under reducing conditions, immunoprecipitated a 130-and a 135-kD band, which corresponded to the ~1 and c~5 subunits, respectively (data not shown). This antibody immunoprecipirated a 155-kD (a5) band and a ll0-kD (~1) band from surface-labeled CD3 ceils under nonreducing conditions (data not shown). Monoclonal antihuman a5 was purified from mouse ascites fluid by nondenaturing liquid chromatography (Oncogene Sciences, Manhasset, NY). Nonimmune rabbit IgG (Copper Biochemical, Malvern, PA) and MOPC 21 tumor cells ascites (Sigma Immunochemicals, St. Louis, MO) were used as polyclonal and monoclonal antibody controls, respectively. Goat whole serum (Sigma Immunochemicals) was used to block nonspeciflc Fc receptors.
Cell Plating
Glass coverslips were cleaned by sonication in 70% ethanol for 30 rain and dried, 1 × 105 of the ECs were plated onto treated cooerslips (18 mm 2) and cultured in DME supplemented with 10% FCS. Higher density of ceils (1 x 106) was plated for those experiments using confluent cells and the cells were cultured for 3--4 d to reach full confluence. To determine whether the expression of VnR and FnR in ECs is dependent on the specific substratum, ECs were seeded onto glass coverslips coated with fibronectin (10 /~g/nd), laminin (20 #g/ml), fibrinogen (10 ~tg/ml), type IV collagen (20 ~g/ml), or vitronectin (10 ~tg/mi). These substrate proteins were reconstituted to their respective final concentrations in PBS, and 100 #1 of the solution was laid on coverslips (18 mm 2) for 2 h at 37"C. After washing, the coated eoverslips were further incubated with 2% BSA in PBS for another half an hour to block unoccupied binding sites. Then 1 x 105 of ECs were seeded onto the coverslips and cultured in the absence of serum for 3 h before treatment (see below).
Preparation of Intact ECM
In some experiments (e.g., adhesion study), ECM sheet derived from confluent ECs was used as the adhesion substrate. Confluent ECs were remooed by incubation with 25 raM ammonium hydroxide for 20 rain at 25°C. The integrity and uniformity of the obtained ECM was characterized as previously described (Menter et al., 1987) . tured in FCS-containing DME for different time periods. FOr dose study, cells were treated with different concentrations of 12(S)-HETE or corresponding amounts of ethanol for 15 rain at 37°C. In some experiments (e.g., flow cytometry studies), cells were continuously exposed to the eicosanoid in 4% BSA (in DME) for different periods of time.
Protein Kinase Inhibitor Studies
To examine the role of different protein kinases in the 12(S)-HETE effect, several general or specific protein kinase inhibitors wore used in the EC retraction assay and immunnfluorescence, i.e., staurosporine (which inhibits the catalytic domain of PKC and other protein kinases), calphostin C (which preferentially interacts with the regulatory domain of PKC; Tamaoki, 1991) , and H8 (which has markedly higher affinities to cyclic nucleotide dependent protein kinases than other kinases; Hidaka et al., 1991) . For the dose and time studies, staurosporine (at the doses of 0.005, 0.05, and 0.5/~M), calphostin C (at the doses of 0.05, 0.5, and 5 ~M) or H8 (at the doses of 0.05, 0.5, 5 and 50/tM) was added, together with 12(S)-HETE (0.1 ~M) or ethanol, to the culture medium. The EC monolayer was monitored by phase contrast microscopy at timed intervals, i.e., at 15, 30, 45, and 60 min after addition.
EC Retraction Assay
To quantitatively determine the role of different protein kinases in 12(S)-HETE-induced EC retraction, we performed the EC retraction assay in the presence of kinase inhibitors, using our established protocol . Briefly, confluent CD3 cells grown on collagen IV in 96-well plates were treated with 12(S)-HETE (0.1/~M) or ethanol, or 12(S)-HETE plus different doses of inhibitors (see above) for 30 rain. Then the cells were washed (three times in PBS), fixed, and incubated with 125I-labeled mAb to collagen type IV (Collaborative Res.; 45 rain, 27 ~g total protein; 1.2 x 105 cpm/~g protein/well). The contents of the wells were washed (3 x with PBS) and removed with 1 ml of 0.5% trypsin and 0.5% type IV collagenase and counted using a Minaxi (AUTO-GAMMA 5000 series) gamma counter (Packard Instrument Company, IL). The results were expressed as total cpm/well. Each condition was run in triplicate and the experiment was repeated three times with comparable results.
Flow Cytometric Analysis of EC Surface Expression of lntegrin Receptors
ECs were nonenzymatically removed from the culture flasks. Briefly, cells were incubated for 15 min in 5 mM EDTA in PBS containing 0.5 % BSA and 10 mM PMSF and then detached by gentle pipetting. Subsequently, cells were washed once with serum-free DME. Cell treatment was performed at 37°C for 15 min with different doses of 12(S)-HETE (0.01, 0.1, 0.5 and 1.0 ~M) or equivalent amounts of ethanol. After washing, cells were fixed with 0.1% sodium azide (in PBS containing 1% BSA) for 20 min on ice. At the end of fixation, cells were washed twice and blocked with normal goat serum (in PBS containing 2% BSA) for 20 rain at 4°C. Thereafter, the cells were incubated with rabbit anti-oct/53 or rabbit (or goat) anti-c~5/31 (1:40) for 45 rain at 4°C. After washing, the cells were incubated with FITCconjugated goat anti-rabbit or rabbit anti-goat IgG (1:200 in PBS containing 4% BSA) for 45 min at 4°C. Finally, cells were postfixed with 1% paraformaldehyde for 15 rain. Samples were measured with an Epics Profile II flow cytometer (Coulter, Hiaieah, FL) for fluorescence intensity. The data were analyzed by comparing the relative fluorescence or mean log fluorescence.
Immunofluorescence
After treatment with 12(S)-HETE or 12(S)-HETE plus kinase inhibitors, ECs grown on various substrates were fixed with 3.7% paraformaldehyde in PBS (containing 1 mM of Ca 2+ and Mg 2+, and 5 % sucrose, pH 7.4) for 15 rain. After washing with PBS, the residual aldehyde groups were neutralized with 1% NH4C1 in PBS. For surface integrin labeling, cells were incubated with 20% normal goat whole serum in 4% BSA-PBS at 37°C for 30 rain to block the nonspecific binding. For intracellular labeling, cells were first permeabilized with the extraction buffer (20 mM HEPES, 300 mM sucrose, 50 mM NaCI, 3 mM CaC12 and 0.5% Triton X-100) for 3 rain, then blocked with the goat whole serum. After extensive rinsing, cells were reacted with various primary antibodies, i.e., monoclonal anti-olv and anti-c~5, 7E3 (at the final concentrations of 10 ~tg/mi), or polyclonal anti-c~5Ol and anti-c~v/33 (at the final concentrations of 30 ~,g/rnl). Then cells were incubated with FITC-conjngated goat anti-mouse, goat antirabbit or rabbit anti-goat IgG (1:200) for 45 min at 37°C. To double-label microfilaments and av/33 or (x5~l, a secondary antibody mixture of FITCconjugated rabbit anti-goat IgG and Rbodamine-conjugated phalloidin was used. Double labeling of vinculin and av/33 or vinculin and cc5/51 was performed using a mixture of primary antibodies (i.e., 10 ~g/ml of monoclonal anti-vinculin and rabbit anti-oc¢/~3 or -c~5/31) and a mixture of secondary antibodies (i.e., goat anti-mouse IgG-FITC and goat anti-rabbit IgG-rhodamine). Samples were mounted on clear slides with glycerol-PBS (9:1) containing 0.1% p-phenylenediamine to retard fluorescence fading. Fluorescence microscopy was performed using a Nikon Orthoplan microscope. Micrographs were recorded on Kodak T-Max 400 panchromatic films (Eastman Kodak Co., Rochester, NY).
Quantitation of cxv83 and c~5131 Surface Expression by Fluorescence Imaging (ACAS Analysis)
To further evaluate the effect of 12(S)-HETE on the surface expression of c~v/33 and a5~l integrins on ECs and to circumvent the potential influence of cell dissociation using EDTA on the integrin surface labeling, adherent CD3 cells on coverslips stained as described for immunofluorescence were analyzed for fluorescence intensity using the ACAS 470 argon laser fluorescence imaging cytometer (Meridian Instruments, Okemos, MI). This automated digital imaging system determines the subeellular distribution and the in situ expression of interested molecules in single cells or in a population of cells. CD3 cells (either 70% confluent or confluent) grown in 33-mm 2 petri dishes were treated with 12(S)-HETE and then surface labeled as described for immunoflunrescence using either rabbit anti-c~v~3 or rabbit anti-c~5~l. The secondary antibody used was goat anti-rabbit IgG conjugated to FITC. Samples were loaded onto the stage of the laser image analyzer and the surface expression of these two integrin receptors determined. The system uses laser irradiation to effect fluorescence excitation. ~ label was excited with the argon laser beam at 488 ran, and the fluorescence emission measured above 530 nm using a 530/30-nm longpass filter. The intensity of each single point emission was recorded and displayed as a color-coded image. Fluorescence intensity is given in arbitrary units per pixel. At least five areas randomly chosen in each sample were analyzed and each condition was run in triplicate. The experiments were repeated with comparable results.
Adhesion Assay
In vitro antibody inhibition studies were performed to determine the relative functions of c~v/33 and c~5/~1 in mediating EC adhesion to and spreading on intact ECM. CD3 cells were detached with trypsin (0.01%) and EDTA (1 mM) and allowed to recover in serum-containing medium for 30 rain at 37°C. After washing, 1 × 105 of suspended cells were put into one of the 24-well plates (Falcon) and the adhesion was conducted in the presence of various dilutions of rabbit anti-o0053 and goat anti-c~5~l, monoclonal anticdIb//33 (7E3), or equivalent amounts of nonimmune rabbit IgG (in DME without serum) for 30 rain at 37°C. The assay was stopped by aspirating off nonadherent cells, washed and then fixed with 3.7% paraformaldehyde. Each condition was run in quadriplicate and the experiment was repeated at least three times with comparable results. The number of adherent cells was determined as described previously .
Antibody Perturbation Study
Specific antibodies to ccv/53 and c~5/31 or to the separate subunits (i.e., oN and c~5) were used to determine the roles of these two intagrin receptors in maintaining the integrity of EC monolayer. Confluent CD3 cells grown on uncoated coverslips were washed twice with DME containing 2% BSA. Rabbit anti-av/53, rabbit anti-c~5jS1 or nonimmune rabbit IgG (final concentration 30 ~g/ml), or monoclonal anti-o~v, monoclooal anti-c~5, monoclonal 7E3 or MOPC ascites (final concentration 10/tg/ml) were diluted with 1% FCS-contalning DME. 200/zl of the above solution was added onto each coverslip. Then ECs with the various antibodies or control IgG fractions were cultured for different intervals at 25°C, and the integrity of the EC monolayer was monitored by both phase-contrast microscopy and F-actin staining using phalloidin. Cells were fixed at several time points, i.e., 15 rain, 30 min, 1, 2, and 24 h after antibody addition.
Immunoblotting
Unlabeled CD3 cells were scraped off the culture flasks into the TNC lysis buffer (0.01 M Tris-acetate, pH 8.0, 0.5% NP-40, and 5 mM Ca 2+) containing a cocktail of protease inhibitors (10 mM PMSF, 1 mM leupeptin, 1%
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aprotinin, 1 #g/ml of pepstatin and chymostatin) and extracted on ice for 20 rain. The whole cell lysates were centrifuged at 14,000 g to obtain the supernatants. Proteins were separated on 7.5% SDS-PAGE under both reducing (5 % 2-mercaptoethanol) and nonreducing conditions. Then proteins were transferred to nitrocellulose membrane and the target proteins were detected using the ECL (Enhanced Chemiluminescence) Western blotting detection kit (Amersharn, Arlington Heights, IL) as described previously (Tang et al., 1993) . To quantitatively determine whether 12(S)-HETE alters the protein level of ctv/$3 integrin, confluent CD3 cell monolayers grown in six-well culture plates were treated with 0.1 #M 12(S)-HETE or ethanol for 5 min and then transferred to FCS-containing DME and cultured for different time intervals (i.e., 5, 15, 30, 60, and 120 min). Ceils were harvested with the TNC lysis buffer and the supernatants obtained as described above. An equal amount of protein (as determined by Bradford) was loaded onto a denaturing 7.5 % SDS-PAGE under reducing conditions and proteins transferred to nitrocellulose paper as described above. The amount of av/$3 integrin was probed by a monoclonal antibody (OPG-2) recognizing the/$3 subunit and the intensity of the band determined by scanning using an XL Ultrasean densitometer.
Semi-quantitative RT-PCR
To determine whether 12(S)-HETE has any effect on the 00//33 and c~5/31 expression at the transcriptional level, the integrin mRNAs were amplified by RT-PCR (Chen et al., 1992) and quantitated by Southern blotting using cry, ors, /$1, or/$3 cDNA as respective probes. Total RNA was extracted from confluent CD3 cells (treated with ethanol or 0.1 #M of 12(S)-HETE for 1, 4, or 24 b) with guanidinium thiocyanate-CsCl method (Chang et al., 1992) . One gg of total RNA was reverse transcribed in 20 #l solution containing 50 mM "Iris (pH 8.3), 75 mM KCI, 3 mM MgCl2, 10 mM DTT, 0.5 mM dNTPs, 20 U of RNasin (Promega), 1 /zM of anti-sense primer, 200 units of M-MLV reverse transcriptase (GIBCO BRL) at room temperature for 15 min then at 37°C for 1 h. To the 20 #l of reverse transcriptase reaction, 1 #M of the sense primer, 80 #l of 1 x PCR buffer (20 mM Tris pH 8.3, 50 mM KC1, 2.5 mM MgCl2, 0.1 mg/ml BSA) and 1 U AmpliTaq DNA polymerase (Perkin Elmer Corp., Norwalk, CT) were added and PCR was run in the GeneAmp PCR system 9600 (Perkin Elmer Corp. . 20 #1 of PCR-amplified cDNA was migrated on a 2% agarose gel and transferred to Genescreen Plus membrane (NEN, Du pont) using a PosiBlot Pressure Blotter (Stratagene, La Jolla, CA). DNA was UV-linked to the membrane, hybridized with 32P-labeled cDNA probes and the intensity of the bands determined by scanning with a LKB Ultrascan XL laser densitometer.
Results
12(S)-HETE Induces EC Retraction which Is Inhibited by Calphostin C But Not by H8
Normal CD3 ECs form tightly apposed, "cobblestone"dike monolayer in culture (Fig. 1 a) . Treatment with 0.1 gM of 12(S)-HETE induced a retracted cell phenotype and formation of cell-cell gaps (Fig. 1 b) . Calphostin C (Fig. 1 c) , a selective PKC inhibitor (Tamaoki, 1991) , at a dose of 0.05 gM (data not shown) or 0.5 #M, applied together with 12(S)-HETE, significantly inhibited 12(S)-HETE-induced CD3 cell retraction. The effect was more prominent at a higher dose (5 #M) of calphostin C (Fig. 1 d) . By comparison, HS, a PKA inhibitor (Hidaka et al., 1991) , at a dose of 5 #M (Fig.  1 e) or even higher (up to 50 #M, data not shown) did not demonstrate any effect. Staurosporine at all doses examined (i.e., 0.005, 0.05, 0.5, and 5 #M) displayed less of an inhibitory effect than calphostin C on 12(S)-HETE-induced EC retraction (Fig. 1 f) . These inhibitors alone, at the doses tested, did not significantly alter the morphology of EC monolayer, although staurosporine at high doses (e.g., 5 #M) appeared to induce a retractive phenotype of EC by itself (data not shown). Quantitative measurement of EC retraction using labeled anti-collagen IV binding assay (14) was performed to evaluate the effects of these protein kinase inhibitors and the results confirmed the morphological observations (data not shown).
Expression and Functional Characterization of EC av[33 and a5[31
The subcellular distribution of ctv~3 and ct5/31 integrins in microvascular CD3 ECs was studied after plating cells on coverslips for various time periods. These two integrin receptors demonstrated different localization patterns (Fig.  2) . Subconfluent CD3 cells (4 h after plating) expressed c~v~3 prominently at the focal adhesions, colocalizing with actin microfilaments (Fig. 2, a and b, arrowheads) and vinculin (data not shown; also see Fig. 7 ). When ECs reached confluency, the otv/33-containing focal adhesions were distributed at both the cell body and cell-cell borders and continued to colocalize with the stress fibers (Fig. 2, c and d) . In contrast, a5/31 in microvascular ECs appeared to follow a different distribution pattern. In subconfluent CD3 cells (4 h after plating), c~5/31 did not demonstrate typical focal adhesion labeling, but a line-or strand-like staining pattern reminiscent of extracellular fibronectin staining (Fig. 2 f) . In addition, ot5/31 demonstrated only occasional and very weak colocalization with stress fiber endings (Fig. 2, e and f arrowhead) and vinculin-containing focal adhesions (data not shown; also see Fig. 7 ). In confluent, and especially in postconfluent CD3 monolayers, ct5/31 was enriched primarily and almost exclusively to the cell-cell borders (with very little cell body focal adhesion labeling) and codistributed with the cortical actin filaments (Fig. 2, h and g, arrow- heads), demonstrating a colocalization with extracellular fibronectin (data not shown) but not significantly with vinculin-containing focal adhesions (data not shown; also see Fig. 7 ). Staining of the large vessel ECs (RAEC) with the same antibodies revealed an identical distribution pattern (data not shown; also see Tang et al., 1993) . When CD3 microvessel ECs were plated on individual specific adhesive ligands, the expression of these two integrins in focal adhesions demonstrated a clear substrate dependency. CD3 cells expressed c~v/33 to focal adhesions when cells were plated on vitronectin or fibrinogen, but not on fibronectin, collagen IV or laminin (data not shown). Similarly, ct5/31 was enriched to focal adhesions only when the cells were plated on fibronectin, but not on other substrates such as laminin, collagen IV, fibrinogen or vitronectin (data not shown).
CD3 cell adhesion to intact ECM was performed in the presence of various concentrations of rabbit anti-ave3, 7E3 (a monoclonal against the crib//33 complex that cross reacts with ctv/33 but not with ot5~l; Fitzgerald and Phillips, 1989; Charo et al., 1987; Grossi et al., 1989) and goat anti-a5/~l (Fig. 3) . The results indicated that all three antibodies inhibited EC adhesion to ECM in a dose-dependent manner (Fig. 3 A) . Experiments with rabbit anti-c~5/31 also demonstrated an inhibitory effect on CD3 adhesion to ECM (data not shown). When these antibodies or monoclonal anti-oc¢ or andi-ot5 were added to confluent CD3 monolayers, the EC sheet was disrupted as revealed by both phase-contrast microscopy (data not shown) and actin staining (Fig. 3 B) . The antibody effect was time dependent. 15 min after adding polyclonal anti-o~v~3 or monoclonal anti-otv, but not other antibodies (i.e., antibodies to c~5/~1 or c~5), retracted EC morphology, formation of cell-cell gaps, and decreased staining of stress fibers were observed (data not shown). By 60 min, as shown in Fig. 3 B, these alterations became more prominent with anti-oc~/~3 and anti-tx, v (Fig. 3 B, b and c) . 7E3 demonstrated a disrupting effect comparable to that of the anti-av (Fig. 3 B, d ). By comparison, both rabbit antic~5/~1 (Fig. 3 B, e) or goat anti-c~5/~2 (data not shown) and monoclonal anti-or5 (Fig. 3 B, f ) produced only a slight disruption of the EC monolayer. Rabbit IgG treatment did not result in any alteration of the confluent CD3 monolayer (Fig.  3B, a) .
12(S)-HETE Redistributes EC ~v133-containing Focal Adhesions
Both confluent (Fig, 4 a) and subconfluent (Fig. 4 b) cells expressed otv133 in focal adhesions at the cell body as well as along the cell-ceU borders (cell edges) when stained with polyclonal anti-otv/33. This distribution pattern is very similar to that of vinculin (see Fig. 7 ). 12(S)-HETE induced a similar effect on otv133 distribution to its effect on vinculin (unpublished observations). 12(S)-HETE induced a series of time-dependent alterations in the distribution pattern of otv~3-enriched focal adhesions. 5 rain after stimulation, no detectable retraction was observed by light microscopy. However, the typical focal adhesion labeling of o~v/~3 was disrupted in groups of cells in focal areas. In these cells, av/~3-containing focal adhesions appeared to be "cleaved," Figure 3 . Functional characterization of EC otv/53 and c~5/51. A, adhesion to ECM was performed with resuspended CD3 cells in the presence of rabbit anti-otv/33 (30/~g/ml) (I), goat, or rabbit (data not shown), anti-~5/~l (30/~g/ml) (m), monoclonal anti-c~Wo//33 7E3 (10 izg/ml) ([]), or nonimmune rabbit IgG (30 ttg/ml) for 30 min. Each condition was run in quadruplicate, the number of adhered cells was determined as described (Horm et al., 1989) , and the results were expressed as the percentage of the adhesion relative to the control (rabbit IgG treatment). The SD was always < 5 % (data not shown). B, antibody perturbation study. Confluent CD3 monolayer was incubated with nonimmune rabbit IgG (30 #g/rul, a), rabbit anti-c~v/33 (30 t~g/ml, b), monoclonal anti-coy (10 #g/ml, c), 7E3 (10 #g/ml, d), rabbit anti-a5/31 (30 #g/ml, e), goat anti-~5/31 (30 tLg/ml; data not shown), monoclonal anti-c~5 (10 tzg/ml, f), or MOPC ascites (10 ~g/ml, not shown) for different time intervals. The integrity of the EC sheet was monitored by actin staining. Shown is 60 rain of incubation. Bar, 8 tzm.
leading to formation of numerous small otv/33-enriched focal adhesions (data not shown). As retraction developed in the CD3 monolayer, 15 min after 12(S)-HETE (0.1 t~M) treatment, the otv/33-contalning focal adhesions were decreased at both the cell body and periphery (Fig. 4 c, single arrowheads; Fig. 4, d, double arrowheads) , especially for those cells in the retracted area. In some cells in or near the retracted area, large patches of "merged" c~v/33-containing focal adhesions could be observed (Fig. 4 c, double arrowheads) . Temporally, these patches of otv/33 were observed subsequent to the redistributed, "cleaved" otv/33-containing focal adhesions, suggesting that the former (i.e., patches) might represent a further rearrangement of (xv/33-enriched focal adhesions. By 30 min, large areas of exposed matrix could be easily discerned in retracted areas (data not shown), and CD3 cells demonstrated a greater decrease in their cellbody otv/33 plaques (Fig. 4 f, double arrowheads) and only a few residual "aggregated" o~v/33-containing focal adhesions could be observed at the cell edge (Fig. 4 f, single arrowheads) . 1 h after treatment, a further decrease in the staining of c~v/33-enriched focal adhesions was observed both in the cell body (Fig. 4, e and h, arrowheads) and the cell margin. 4 h after 12(S)-HETE stimulation, cells still demonstrated decreased overall labeling of av/33, especially at the cell edges (data not shown). By 24 h, cells recovered their normal "cobblestone" morphology and the complete monolayer was reformed. There was a corresponding increase in oLv/~3-containing focal adhesions, both at the cell body and the cell periphery (Fig. 4 g) .
12(S)-HETE-induced EC ~v{33 Rearrangement Is Inhibited by PKC Inhibitor Calphostin C
As in the retraction study (Fig. 1) , 12(S)-HETE treatment (30 min) induced EC retraction and decreased o~v/33 staining (Fig. 5 b) . Simultaneous treatment of CD3 cells with 0.1 pM of 12(S)-HETE and 0.5/~M of calphostin C totally inhibited both EC retraction and the decrease in otv/33 staining (Fig.  5 c) on 12(S)-HETE-induced EC retraction and otv/33 rearrangement (Fig. 5 d) . Again, staurosporin demonstrated a less potent effect than calphostin C (data not shown).
12(S)-HETE Does Not Induce a Defined Rearrangement of t~5[31 Integrin
As described above, CD3 cell ct5/31 demonstrated a different distribution pattern from that of the a,v/33 integrin. In confluent (Fig. 6 a) and especially in postconfluent (data not shown) CD3 monolayer, a5/31 was almost exclusively enriched to the cell-cell borders (Fig. 6 a, arrowheads) , colocalizing with cell cortical microfilaments and extracellulax fibronectin but not significantly with typical vinculincontaining focal adhesions which are characteristically localized to the cell-matrix contact sites. Interestingly, in contrast to its effect on the redistribution of EC otv/33, 12(S)-HETE did not demonstrate any specific effect on the ot5/31 receptor in both confluent (Fig. 6 , c and e) and subconfluent (Fig. 6, d and f ) CD3 cells. No alteration in the distribution pattern of a5/31 was observed preceding EC retraction following 12(S)-HETE stimulation (i.e., 5 min post treatment) (data not shown), in contrast to the rearrangement of av/33-containing focal adhesions (see above) at this time point. EC retraction was observed at 15 min (Fig. 6 c, asterisks) and became intensified by 60 min (Fig. 6 e, asterisks) after treatment. Simultaneously the typical cell-cell border staining pattern of tx5131 was disrupted, however, no clear pattern of alteration was observed. Similarly, no definitive rearrangement or quantitative alteration of c~5/31 integrin was observed in subconfluent CD3 cells (Fig. 6, compare b with d  and f ) . By 24 h, EC monolayer reformed and typical cell-cell border staining of a5/31 was again observed (data not shown). Staining with goat anti-or5/31 revealed identical results (data not shown).
Differential Effects of 12(S)-HETE on ~v/J3 and ~5~1 May Result from Different Distribution Patterns of These Two Integrins
The mechanism by which 12(S)-HETE exerts a differential effect on these two integrins is at present unclear. One possible explanation may be different subeellular localizations of ctv/33 and ot5B1 integrins in microvascular ECs. Double immunofluorescent labeling of integrins and vinculin, a protein marker for focal adhesions, was performed to examine this possibility. As shown in Fig. 7 , os/33-containing focal adhesions (Fig. 7 a) demonstrated an identical codistribution with vinculin-containing focal adhesions (Fig. 7 b, double  arrowheads) . Colocalization of ¢xv/~3 and vinculin in focal adhesions also was observed in fully confluent CD3 monolayers (data not shown). In contrast, a5/31 integrin (Fig. 7  c) was present in strand-like structures which were reminiscent of extracellular fibronectin and they did not demonstrate a significant eolocalization with vinculin-containing focal adhesions (Fig. 7 d, arrowheads) . In confluent ECs, c~5/31 was primarily localized to the cell-cell borders and did not demonstrate colocalization with vinculin-containing focal adhesions (data not shown). Previous work demonstrated that 12(S)-HETE also disrupted vinculin-containing focal adhesions in retracted CD3 ECs (Tang et al., submitted) . Therefore, it appears that 12(S)-HETE specifically disrupts the integrity of focal adhesions.
12(S)-HETE Enhances the Surface Expression of av[33 But Not ~5131
We recently observed that a 15-rain treatment of large vessel EC (i.e., RAEC) with 0.1 #M of 12(S)-HETE significantly increased the surface labeling for oevB3 using mAb7E3 (Tang et al., 1993) . In this study, we found that 12(S)-HETE also stimulated the surface expression of otv:33 on microvessel CD3 cells. Both adherent and resuspended (via nonenzymatic dissociation; see Materials and Methods) CD3 ceils were used for surface labeling of oevj33 and a5/31 integrins. Immunofluorescence studies (data not shown) and digitized image analysis (Fig. 8 ) using adherent ECs indicated that CD3 cells stimulated with 0.1 #M of 12(S)-HETE demonstrated enhanced surface expression of otvB3. This stimulating effect of 12(S)-HETE was found to be both time and dose dependent. 15 min of treatment by 0.1 /~M of 12(S)-HETE led to an increase in otv/33 surface labeling. By 1 h, the 12(S)-HETE effect reached peak level (Fig. 8 c) and the mean relative fluorescence intensity (represented by the relative color values as shown in Fig. 8 ) of at least five individual measurements in each condition was increased from 389 + 59 (arbitrary units) in control (Fig. 8 a) to 1286 5:371 in the 12(S)-HETE-treated (Fig. 8 c) group. As shown in the composite histogram in Fig. 8 e, there was a dramatic shift (i.e., increase) in the average fluorescence of the 12(S)-HETEtreated samples (red bars) compared with the control (green bars). After 1 h, the surface expression of oev/33 rapidly decreased to the unstimulated level (data not shown). No effect of 12(S)-HETE on the surface expression of c~5/31 was observed (Fig. 8, b, d , and f). At the basal (i.e., unstimulated) level, CD3 cells appeared to express more o~5/31 than otvfl3 on their surface (Fig. 8, compare a and b) . 12(S)-HETE treatment did not significantly alter the surface expression level ofa5/~l (1049 5:118 in control vs 1020 + 171 in 12[S]-HETE-treated group) (Fig. 8, b and d) . No shift in fluorescence intensity of ot5/31 surface labeling was observed after 12(S)-HETE stimulation (Fig. 8f) . Quantitative flow cytometric measurement of fluorescence intensity revealed a dose-dependent effect on otvB3 surface expression by 12(S)-HETE (15-min stimulation), with a maximum effect on 0.1 /zM (increasing the fluorescence intensity by more than twofold; data not shown). In contrast, 12(S)-HETE did not increase the overall surface expression of ot5/31 as revealed by flow cytometry using rabbit anti-a5#l (data not shown).
12(S)-HETE Effect on ~v~3 Is a Posttranscriptional Process
12(S)-HETE demonstrated two seemingly opposite effects on EC oLv/33 integrin receptors, i.e., rearranging (decreasing) c~v/33 at focal adhesions and increasing ¢xv/33 surface expression. Semi-quantitative RT-PCR followed by Southern hybridization using specific eDNA probes for different integrin subunits was performed to determine whether 12(S)-HETE alters ocv/33 expression at the transcriptional level. The same experiment was also run for c~5/31. The results in- Figure 8 . 12(S)-HETE exhibits differential effects on the surface expression of EC c~v/~3 and t~5/~l. Adherent subeonfluent or confluent (data not shown) CD3 cells were treated with ethanol (a and b) or 0.1/zM 12(S)-HETE (c and d) for 5 rain, cultured for different time periods (shown here is 60 min after treatment) and then surface stained for txvfl3 (a and c) or c~5/~1 (b and d) with rabbit anti-av/~3 and dicated that 12(S)-HETE did not significantly alter the mRNA levels of otv/~3 and o~5fll integrins. To further support the concept that 12(S)-HETE-induced alterations in otvfl3 may be posttranscriptional, quantitative western blotting of/$ 3 in whole cell lysates using monoclonal anti-/S3 antibody (OPG-2) was performed. The results indicated that there was no significant alterations in the overall level of fl 3 proteins after 12(S)-HETE (0.1 /xM) treatment (data not shown), as determined by densitometric scanning.
Discussion
Physiologically ECs form a continuous and polarized boundary between flowing blood and the underlying tissues. Specific interactions of lymphocytes (Ford et al., 1976) , neutrophils (Belloni and Tressler, 1989) , and circulating tumor cells (Pauli and Lee, 1988; Weiss et al., 1989) , with components of the vascular wall are important for their targeting to different tissues and their exit from circulation. The maintenance of normal hemostasis, the regulation of inflammation, and prevention of blood-borne tumor cells from dissemination, all depend on the physical intactness of the EC monolayer, which in turn is determined by the wellorganized cell-cell and cell-matrix adhesion structures. Integrins are the most important transmembrane molecules linking ECM to intracellular cytoskeleton. Cultured large and small vessel ECs express a variety of/~1 integrin complexes as well as the t~IIb//33-related t~v/33 complex (Fitzgerald et al., 1985; Dejana et al., 1990; Albelda et al., 1989; Kramer et al., 1990) . Using immunofluorescence, immunoblotting, immunoprecipitation with specific antibodies, as well as adhesion assay and antibody perturbation study, we demonstrated that both large vessel (unpublished observations) and microvessel ECs express otv/33 and u5/$1, and that both receptors are functional in mediating initial EC adhesion to ECM and maintaining the integrity of the established monolayer. It is well known that the ECM could modulate the organization of EC cytoskeleton and cell shape (Young and Herman, 1985) . Distribution of EC integrin receptors to specific cell microdomains, i.e., the cell-cell or cellmatrix contact sites, is also regulated by specific ECM ligands (Cheng and Kramer, 1989; Dejana et al., 1988) . In our experiments, we also noted that the distribution of both et5#l and o~v/~3 in focal adhesions is dependent on specific substratum composition. In confluent microvessel EC monolayer (i.e., EC growing on their own natural ECM), c~5/31 and otv~3 appear to follow different distribution patterns; the former primarily concentrated at the cell-cell borders colocalizing with cell cortical microfilaments and extracel!ular fibronectin while the latter codistributed with typical vinculin-containing focal adhesions in both the cell body and cell-cell borders. This different distribution pattern of otvfl3 and ot5/31 implies that these two integrins may play a differential role in mediating EC-matrix interactions and maintaining the EC monolayer integrity and also provides an explanation for the specific effect of 12(S)-HETE on otv/33. 12(S)-HETE induced a time-dependent redistribution of otv/33-containing focal adhesions and there exists a causeand-effect relationship between 12(S)-HETE-induced otv/33 rearrangement and EC retraction. 5 min after 12(S)-HETE stimulation when no EC retraction could be detected (both morphologically and quantitatively), redistribution (i.e., cleavage) of ctv/$3-containing focal adhesions was observed. Subsequently rearrangement of otv/~3 integrin led to an overall decreased localization of this integrin to focal adhesions, the most important cellular structures linking cells to ECM through the cytoskeleton. The general alterations of otv/~3-containing focal adhesions are very similar to those of vinculin plaques (unpublished observations), i.e., an eventual decrease in those retracted ceils, implying that 12(S)-HETE has a global impact on the focal adhesions. Focal adhesions are complex cellular structures involved in transducing signals from the outside to the inside, or vice versa, through a chain of proteins, i.e., extracellular adhesive glycoproteins such as fibronectin and vitronectin linked to membranespanning integrins which are further connected to cytoskeleton via talin, vinculin, ot-actinin, etc (for review, see Burridge et al., 1988) . A number of regulatory proteins, such as tyrosine kinases (e.g., pp60 ~-s~, Burridge et al., 1988) , proteases (Beckerle et al., 1987) , PKC isoforms Oaken et al., 1989) , and so on, are also concentrated at focal adhesions to maintain the dynamic entity. How 12(S)-HETE alters the normal organization of otv/33 integrins is currently unknown, but two nonexclusive alternatives could be hypothesized. One possibility is that ctv/~3 redistribution resuits from the alteration of other components of the focal adhesions, such as microfilament, vinculin or t~-actinin. In CD3 ceils, av/$3 integrin is colocalized with vinculin, stress fiber endings, and ot-actinin in focal adhesions (this study and unpublished observations). In fact, we have found that 12(S)-HETE rearranges vinculin-enriched focal adhesions, reorganizes the actin filaments, and mobilizes ot-actinin to the membrane "ruffles" . All of these alterations would undoubtedly disrupt the normal ctv/~3-containing focal adhesions. Preliminary results obtained from vinculin-otv/~3 double labeling experiments suggest that alteration (i.e., disruption and decrease) of vinculin-containing focal adhesions appear to occur before that of otv/~3-containing focal adhesions. The other possibility is that 12(S)-HETE directly exerts its effect on av/33, for instance, through phosphorylation, since this eicosanoid alters the organization of the cytoskeletal elements by enhancing PKC-dependent phosphorylation . Several integrin subunits, including/$3, can be phosphorylated (Hillery et al., 1991; Haimovich et al., 1991) . Interestingly, 12(S)-HETE-induced etv/~3 rearrangement also appears to be dependent on PKC, since its effect could be totally abolished by the selective PKC inhibitor calphostin C, but not by the protein kinase A inhibitor H8. This finding is in accord with our recent observations that this eicosanoid induces EC cytoskeleton alterations in a PKC-dependent manner , and that it activates tumor cell PKC by translocating the enzyme from the cytosol to the plasma membrane rabbit anti-c~5/~l, respectively. After incubation with secondary antibody, cells were subjected to digitized surface fluorescence analysis on an ACAS 470 laser image analyzer as detailed in Materials and Methods. e andfrepresent composite histograms of a distinct population of CD3 cells stained for t~v/33 (e) or ct5/31 (f). Green bars, control samples: red bars, 12(S)-HETE-treated samples. Bar, 2 #m. (Liu et al., 1991) . It would be interesting to determine which isoform of PKC is responsible for the 12(S)-HETE-induced otvB3 rearrangement. Preliminary results indicate that, in addition to the PKC-ot, CD3 cells also express two other isoforms. Interestingly, in all of our inhibitor studies, we observed that staurosporine is a less effective inhibitor than calphostin C (based on their relative IC5o values; see Materials and Methods) on 12(S)-HETE-induced cytoskeleton phosphorylation and reorganization , avB3 rearrangement and EC retraction (this study). One possible explanation for these observations is that staurosporine (which has very similar IC50 values for most protein kinases) exerts inhibitory effects on, in addition to PKC, a variety of other protein kinases including PKA, myosin light chain kinase and tyrosine kinases. It is known that in many circumstances these protein kinases play differential or antagonizing roles. Therefore, the promiscuous effects of staurosporine may mask its "specific" action on PKC. In addition, many groups have reported that stanrosporine possesses some biological activities (such as inducing a dissolution of microfilaments) independent of its effect on PKC (Hedberg et al., 1990) . We also observed (both morphologically and quantitatively) that higher doses of staurosporine actually disrupted the EC monolayer integrity.
12(S)-HETE is a monohydroxy fatty acid and a lipoxygenase metabolite of arachidonic acid produced by platelets, leukocytes, and a variety of cell types including many solid tumor cells (for review, see Spector et al., 1988; Marnett et al., 1990; Liu et al., 1991) . During hernatogenous spreading of tumor cells 12(S)-HETE may reach a concentration in localized foci of tumor cell-platelet-leukocyte-EC interactions high enough to initiate its biological activity on these interacting cells. Our previous work has demonstrated that this eicosanoid enhances the surface expression of the integrin receptor cdlb//33 in cultured B16 amelanotic melanoma (B16a) and Lewis lung carcinoma cells Chopra et al., 1991) . More recently, we observed that 12(S)-HETE upregulated otv#3 integrin surface expression in large vessel EC, resulting in an enhanced tumor cell adhesion to the stimulated EC monolayer (Tang et al., 1993) . In the present study, we observed that 12(S)-HETE increased, in a dose-and time-dependent manner, the surface expression of otv/33 in microvessel CD3 cells, as revealed by immunofluorescence studies, digitized imaging analysis and flow cytometry. The expression of individual integrins is strictly regulated during tissue development and cell segregation. Cell-and matrix-adhesion molecules, as well as ECM components are known to respond to and be regulated by signals from growth factors and cellular oncogenes (Damsky and Bernfield, 1990) . Typical examples are the upregulated mRNA expression of integrin receptors (all 3 major subfamilies) by the transforming growth factor-B (Ignotz et al., 1989) , the downregulation of c¢v/~3 surface expression in ECs by 13-hydroxyoctadecadienoic acid (13-HODE), a lipoxygenase metabolite of linoleic acid (Buchanan et al., 1990) , and enhanced surface expression of otlIb/33 expression by 12(S)-HETE in tumor cells . In this study, we observed two effects of 12(S)-HETE on the EC av/~3, i.e., a decreased focal adhesion labeling and an increased surface staining. At present, we are uncertain about the relationship between these two phenomena. However, it is highly possible that increased ctvB3 surface expression after 12(S)-HETE stimulation may, at least partly, result from decreased (or mobilized) focal adhesion localization since these two processes appear to be temporally related. Integrins, after their synthesis, are targeted to different microdomains of the cell such as the cell-cell border, focal adhesions and the cell surface. What determines the route of sorting or whether there is any minor difference between the integrin receptors targeted to different cellular microdomains is currently unknown. What is known is that localization to each of these microdomains is not fixed, but under constant exchange depending on the status of the cells (e.g., motile vs resting). Another potential mechanism for 12(S)-HETEenhanced t~v/33 surface expression is mobilization of this integrin receptor from an intracellular pool to the plasma membrane. Recently we observed that 12(S)-HETE enhanced the surface expression of the integrin M1b/33, a close relative to cr¢/33, in B16a tumor cells and that this effect was mediated through cytoskeleton-dependent translocation (Chopra et al., 1991) . These results suggest that a similar mechanism may exist for av133 upregulation in EC by 12(S)-HETE. The 12(S)-HETE effect on tumor cell MIb/33 surface expression was found to be time-dependent (within 1 h), independent of transcriptional activation, but dependent on the tumor cell cytoskeleton, i.e., microfilaments and intermediate filaments (Chopra et al., 1991) . In this study, the stimulation of c~v/33 surface expression in CD3 ceils by 12(S)-HETE effect is also time-dependent, and proved to be a posttranslational process. Semi-quantitative RT-PCR followed by Southern hybridization did not reveal significant alterations in the mRNA levels of both cry and/33 after 12(S)-HETE stimulation. Semi-quantitative immunoblotting of the /33 subunit also did not reveal any significant alterations in the protein level after 12(S)-HETE treatment. It is possible that the increased cell surface labeling of ctv133 results from the decreased focal adhesion enrichment of this integrin receptor as well as from increased protein translocation from a cytosolic pool to the membrane. Theoretically, decreased focal adhesion labeling of c~v/33 may result from decreased protein synthesis, however, this possibility has been excluded by quantitative Western blotting and RT-PCR. Alternative possibilities include diminished targeting of o~v/33 to the focal adhesions due to post-translational protein modification (such as phosphorylation), and/or increased proteolytic cleavage due to protease activation. However, at present, substantiative evidence for these possibilities is lacking.
In contrast to av/33, c~5/51 did not undergo a well-defined and time-dependent rearrangement (e.g., redistribution and decrease of c~5~l-containing focal adhesions), although the typical cell border localization of o~5131 in confluent EC monolayers was disrupted following 12(S)-HETE stimulation. No specific pattern of alteration in o~5/31 was observed, nor did 12(S)-HETE alter the surface expression of a5/31 in ECs. Not unexpectedly, 12(S)-HETE did not alter the mRNA level of EC ct5 or ~1. Unlike otvfl3-containing focal adhesions whose rearrangement precedes development of EC retraction, the disruption of cell border localization of o~5~1 was observed to occur simultaneously with EC retraction. This observation suggests that the disruption of c~5131 localization to the cell-cell borders is not an initiating factor in retracting ECs although it may contribute to the later phase of EC retraction. In microvessel ECs, integrin o~5/31, despite cell junction localization, appears to be less impor-tam than av/~3 (which are localized in typical cell matrix contact sites or focal adhesions in both the cell body and cellcell borders) since anti-or5/31 antibodies are much less potent than anti-av/~3 in disrupting the established EC monolayer. Most probably, the differential effect of 12(S)-HETE on otv/33 and c~5~1 is due to the differential distribution patterns of these two integrins, i.e., av/~3, but not ol5/~1, is cedistributed with vinculin-containing focal adhesions. We conclude that 12(S)-HETE appears to affect specifically the protein components, e.g., microfilaments, vinculin, cr-actinin and ctv/~3, in focal adhesions.
The significance of c~v/~3 rearrangement after 12(S)-HETE treatment can be multi-factorial, cw/~3 is organized at focal adhesions and demonstrates colocalization with vinculin. In addition, it connects the intracellular cytoskeleton to the extracellular adhesive glycoproteins, and thus makes the cell and its environment an integrated system, av/~3, like vinculin, is also localized to the intercellular junctions. Therefore we believe that 12(S)-HETE-induced disruption of this integrin organization will alter the normal cell-matrix and cell-cell adhesion, break down the EC monolayer integrity, and contribute to the retracted EC phenotype. The increased cell surface expression of oLv~3, which results from redistribution of focal adhesion-localized o~v/~3 and/or mobilization of av/33 from the cytosolic pool, may increase the adhesivity of blood-borne cells (i.e., leukocytes, tumor cells, etc.) to endothelium (Shaughnessy et al., 1991; Tang et al., 1993) . Enhanced tumor cell adhesion and extravasation due to EC retraction may facilitate metastatic dissemination. Similarly, adhesion of leukocytes to EC and enhanced exudation of blood components (both cellular and acellular) may contribute to inflammatory responses.
